| Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 JP Gérard, D Azria, S Gourgou-Bourgade, I Martel-Laffay, C Hennequin, ... Journal of clinical oncology 28 (10), 1638-1644, 2010 | 946 | 2010 |
| Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised … T Conroy, JF Bosset, PL Etienne, E Rio, É François, N Mesgouez-Nebout, ... The Lancet Oncology 22 (5), 702-715, 2021 | 616 | 2021 |
| Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule E Rullier, C Laurent, F Bretagnol, A Rullier, V Vendrely, F Zerbib Annals of surgery 241 (3), 465-469, 2005 | 570 | 2005 |
| Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer JP Gérard, D Azria, S Gourgou-Bourgade, I Martel-Lafay, C Hennequin, ... Journal of clinical oncology 30 (36), 4558-4565, 2012 | 481 | 2012 |
| Low rectal cancer: classification and standardization of surgery E Rullier, Q Denost, V Vendrely, A Rullier, C Laurent Diseases of the colon & rectum 56 (5), 560-567, 2013 | 348 | 2013 |
| Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial E Rullier, P Rouanet, JJ Tuech, A Valverde, B Lelong, M Rivoire, ... The Lancet 390 (10093), 469-479, 2017 | 347 | 2017 |
| Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival A Rullier, C Laurent, M Capdepont, V Vendrely, G Belleannée, ... The American journal of surgical pathology 32 (1), 45-50, 2008 | 218 | 2008 |
| Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial E Rullier, V Vendrely, J Asselineau, P Rouanet, JJ Tuech, A Valverde, ... The lancet Gastroenterology & hepatology 5 (5), 465-474, 2020 | 179 | 2020 |
| Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: final results of PRODIGE 23 phase III trial, a … T Conroy, N Lamfichekh, PL Etienne, E Rio, E Francois, ... Journal of Clinical Oncology 38 (15_suppl), 4007-4007, 2020 | 178 | 2020 |
| An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment C Cassinotto, J Cortade, G Belleannée, B Lapuyade, E Terrebonne, ... European journal of radiology 82 (4), 589-593, 2013 | 142 | 2013 |
| Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy C Cassinotto, A Mouries, JP Lafourcade, E Terrebonne, G Belleannée, ... Radiology 273 (1), 108-116, 2014 | 140 | 2014 |
| Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm … S Kim, E François, T André, E Samalin, M Jary, F El Hajbi, N Baba-Hamed, ... The Lancet Oncology 19 (8), 1094-1106, 2018 | 124 | 2018 |
| Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas AS Cunha, A Rault, C Laurent, X Adhoute, V Vendrely, G Béllannée, ... Journal of the American College of Surgeons 201 (3), 359-365, 2005 | 123 | 2005 |
| Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma A Rullier, C Laurent, V Vendrely, B Le Bail, P Bioulac-Sage, E Rullier The American journal of surgical pathology 29 (5), 602-606, 2005 | 114 | 2005 |
| Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) A Zaanan, O Bouché, L Benhaim, B Buecher, N Chapelle, O Dubreuil, ... Digestive and Liver Disease 50 (8), 768-779, 2018 | 112 | 2018 |
| Circulating tumor cell clusters: united we stand divided we fall S Amintas, A Bedel, F Moreau-Gaudry, J Boutin, L Buscail, JP Merlio, ... International journal of molecular sciences 21 (7), 2653, 2020 | 96 | 2020 |
| High clinical value of liquid biopsy to detect circulating tumor cells and tumor exosomes in pancreatic ductal adenocarcinoma patients eligible for up-front surgery E Buscail, C Alix-Panabières, P Quincy, T Cauvin, A Chauvet, O Degrandi, ... Cancers 11 (11), 1656, 2019 | 91 | 2019 |
| Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer D Azria, J Doyen, M Jarlier, I Martel-Lafay, C Hennequin, P Etienne, ... Annals of Oncology 28 (10), 2436-2442, 2017 | 84 | 2017 |
| How does chemoradiotherapy following induction FOLFIRINOX improve the results in resected borderline or locally advanced pancreatic adenocarcinoma? An AGEO-FRENCH multicentric … D Pietrasz, O Turrini, V Vendrely, JM Simon, O Hentic, R Coriat, F Portales, ... Annals of surgical oncology 26, 109-117, 2019 | 81 | 2019 |
| Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma A Rullier, C Laurent, M Capdepont, V Vendrely, P Bioulac-Sage, E Rullier The American journal of surgical pathology 34 (4), 562-568, 2010 | 81 | 2010 |
